Strategies for Overcoming Scientific, Regulatory and Business Challenges in Early Drug Development

Join us at our symposium for lunch and presentations that will address challenges, new concepts and strategies for successful early drug development.

This seminar is offered on the following dates and locations:

What you will Learn

• What funding models are available to companies at a National and European level
• How to stratify your preclinical development plan
• Strategic and tactical solutions for accelerating early phase research programs  
• Success routes in partnering with a CRO at early development stages

Agenda

National and European Funding for Biotech companies
Sandra Dubos (Lyon), Nathalie Jaworski and Simon Nardin (Paris)
Chargée de mission Innovation OSEO

CRO partnering - how to make partnering with CRO a success within early clinical drug development
Dr. Philippe Moullier, Scientific Director, Généthon (Lyon)
Dr. Philippe Vivet, Director of Medical Affairs and Clinical Development, D&A Pharma (Paris)

Non-clinical and regulatory strategies to support early clinical development
Dr Anders Neil, Principal Consultant Early Stage, PAREXEL Consulting

Identification and Mitigation of Risks in First-in-Human Clinical Trials - Pitfalls and Challenges
Dr Matthias Grossmann
Vice President and Principal Consultant Early Phase, PAREXEL International

This event is free of charge for members of the biopharmaceutical industry.